Stock Track | AMN Healthcare Soars 7.22% After Beating Q3 Expectations and Positive Q4 Outlook

Stock Track11-07

AMN Healthcare Services Inc (AMN) stock surged 7.22% in 24 hours following the release of its third-quarter 2025 financial results, which exceeded analyst expectations. The healthcare staffing company reported strong performance across its key segments and provided an optimistic outlook for the fourth quarter.

AMN Healthcare reported Q3 revenue of $634.5 million, surpassing the consensus estimate of $618.1 million. While this represents an 8% year-over-year decline, it still beat market expectations. The company's adjusted earnings per share (EPS) of $0.39 significantly outperformed the analyst forecast of $0.21, although it was down 36% compared to the same quarter last year. Net income for the quarter stood at $29.3 million, with a gross margin of 29.1%.

The company's performance was driven by better-than-expected results in its Nurse and Allied Solutions and Physician and Leadership Solutions segments. AMN Healthcare also reported a rebound in staffing orders and higher winter order volume, suggesting improved demand trends. Additionally, the company has enhanced its financial flexibility by refinancing its senior notes and extending its credit facility. Looking ahead, AMN Healthcare provided a positive outlook for Q4, projecting revenue between $715 million and $730 million, with its Nurse and Allied Solutions revenue expected to rise 1-3% year-over-year. The strong quarterly results, coupled with an optimistic future outlook, have fueled investor confidence, leading to the significant stock price surge.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment